Search research articles
Contact Us
Filters
Showing results (221-230 of 277) with videos related to
Page
of 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2015
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Hervé Ghesquieres, Susan L Slager, Fabrice Jardin, et al.
Blood
|
April 3, 2015
The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma
Rebecca L Boddicker, N Sertac Kip, Xiaoming Xing, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCL
Kerstin Wenzl, Matt Stokes, Joseph P Novak, et al.
Blood
|
December 23, 2006
Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)
Sophia S Wang, Susan L Slager, Paul Brennan, et al.
Blood
|
January 29, 2021
Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families
Susan L Slager, Mark C Lanasa, Gerald E Marti, et al.
Blood Cancer Journal
|
June 20, 2024
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, et al.
American Journal of Human Genetics
|
February 1, 2020
Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic Anemia
Sharon A Savage, Mathias Viard, Colm O'hUigin, et al.
Blood
|
May 19, 2019
Recurrent <i>MSC</i> <sup>E116K</sup> mutations in ALK-negative anaplastic large cell lymphoma
Rebecca A Luchtel, Michael T Zimmermann, Guangzhen Hu, et al.
Blood Advances
|
February 15, 2024
Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis
Geffen Kleinstern, Nicholas J Boddicker, Daniel R O'Brien, et al.
American Journal of Hematology
|
October 23, 2015
Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma
Matthew J Maurer, Jean-Philippe Jais, Hervé Ghesquières, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 277) with videos related to
Sort By:
Page
of 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2015
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Hervé Ghesquieres, Susan L Slager, Fabrice Jardin, et al.
Blood
|
April 3, 2015
The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma
Rebecca L Boddicker, N Sertac Kip, Xiaoming Xing, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCL
Kerstin Wenzl, Matt Stokes, Joseph P Novak, et al.
Blood
|
December 23, 2006
Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)
Sophia S Wang, Susan L Slager, Paul Brennan, et al.
Blood
|
January 29, 2021
Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families
Susan L Slager, Mark C Lanasa, Gerald E Marti, et al.
Blood Cancer Journal
|
June 20, 2024
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, et al.
American Journal of Human Genetics
|
February 1, 2020
Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic Anemia
Sharon A Savage, Mathias Viard, Colm O'hUigin, et al.
Blood
|
May 19, 2019
Recurrent <i>MSC</i> <sup>E116K</sup> mutations in ALK-negative anaplastic large cell lymphoma
Rebecca A Luchtel, Michael T Zimmermann, Guangzhen Hu, et al.
Blood Advances
|
February 15, 2024
Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis
Geffen Kleinstern, Nicholas J Boddicker, Daniel R O'Brien, et al.
American Journal of Hematology
|
October 23, 2015
Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma
Matthew J Maurer, Jean-Philippe Jais, Hervé Ghesquières, et al.
Page
of 28